PMID- 22718360 OWN - NLM STAT- MEDLINE DCOM- 20130124 LR - 20211021 IS - 1097-4652 (Electronic) IS - 0021-9541 (Print) IS - 0021-9541 (Linking) VI - 228 IP - 2 DP - 2013 Feb TI - Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-kappaB signaling pathway. PG - 380-92 LID - 10.1002/jcp.24142 [doi] AB - We have previously shown that retinoic acid (RA) has protective effects on high glucose (HG)-induced cardiomyocyte apoptosis. To further elucidate the molecular mechanisms of RA effects, we determined the interaction between nuclear factor (NF)-kappaB and RA signaling. HG induced a sustained phosphorylation of IKK/IkappaBalpha and transcriptional activation of NF-kappaB in cardiomyocytes. Activated NF-kappaB signaling has an important role in HG-induced cardiomyocyte apoptosis and gene expression of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, and monocyte chemoattractant protein-1 (MCP-1). All-trans RA (ATRA) and LGD1069, through activation of RAR/RXR-mediated signaling, inhibited the HG-mediated effects in cardiomyocytes. The inhibitory effect of RA on NF-kappaB activation was mediated through inhibition of IKK/IkappaBalpha phosphorylation. ATRA and LGD1069 treatment promoted protein phosphatase 2A (PP2A) activity, which was significantly suppressed by HG stimulation. The RA effects on IKK and IkappaBalpha were blocked by okadaic acid or silencing the expression of PP2Ac-subunit, indicating that the inhibitory effect of RA on NF-kappaB is regulated through activation of PP2A and subsequent dephosphorylation of IKK/IkappaBalpha. Moreover, ATRA and LGD1069 reversed the decreased PP2A activity and inhibited the activation of IKK/IkappaBalpha and gene expression of MCP-1, IL-6, and TNF-alpha in the hearts of Zucker diabetic fatty rats. In summary, our findings suggest that the suppressed activation of PP2A contributed to sustained activation of NF-kappaB in HG-stimulated cardiomyocytes; and that the protective effect of RA on hyperglycemia-induced cardiomyocyte apoptosis and inflammatory responses is partially regulated through activation of PP2A and suppression of NF-kappaB-mediated signaling and downstream targets. CI - Copyright (c) 2012 Wiley Periodicals, Inc. FAU - Nizamutdinova, Irina T AU - Nizamutdinova IT AD - Division of Molecular Cardiology, Department of Medicine, College of Medicine, Texas A&M Health Science Center, Temple, Texas 76504, USA. FAU - Guleria, Rakeshwar S AU - Guleria RS FAU - Singh, Amar B AU - Singh AB FAU - Kendall, Jonathan A Jr AU - Kendall JA Jr FAU - Baker, Kenneth M AU - Baker KM FAU - Pan, Jing AU - Pan J LA - eng GR - R01 HL091902/HL/NHLBI NIH HHS/United States GR - 1R01 HL091902/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Cytokines) RN - 0 (NF-kappa B) RN - 0 (Tetrahydronaphthalenes) RN - 5688UTC01R (Tretinoin) RN - A61RXM4375 (Bexarotene) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 3.1.3.16 (Protein Phosphatase 2) SB - IM MH - Animals MH - Apoptosis/*drug effects MH - Bexarotene MH - Cytokines/biosynthesis MH - *Cytoprotection MH - Gene Expression Regulation/drug effects MH - Hyperglycemia/*complications MH - I-kappa B Kinase/metabolism MH - Male MH - Myocytes, Cardiac/*drug effects MH - NF-kappa B/*drug effects MH - Phosphorylation MH - Protein Phosphatase 2/drug effects MH - Rats MH - Rats, Zucker MH - Signal Transduction/*drug effects MH - Tetrahydronaphthalenes/pharmacology MH - Tretinoin/*pharmacology PMC - PMC3470832 MID - NIHMS385058 EDAT- 2012/06/22 06:00 MHDA- 2013/01/25 06:00 PMCR- 2014/02/01 CRDT- 2012/06/22 06:00 PHST- 2012/06/22 06:00 [entrez] PHST- 2012/06/22 06:00 [pubmed] PHST- 2013/01/25 06:00 [medline] PHST- 2014/02/01 00:00 [pmc-release] AID - 10.1002/jcp.24142 [doi] PST - ppublish SO - J Cell Physiol. 2013 Feb;228(2):380-92. doi: 10.1002/jcp.24142.